Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
✍ Scribed by Mahvash Zakikhani; Marie-José Blouin; Esther Piura; Michael N. Pollak
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 492 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Previous work from our laboratory has shown that human ether à go‐go (hEAG) K^+^ channels are crucial for breast cancer cell proliferation and cell cycle progression. In this study, we investigated the regulation of hEAG channels by an insulin‐like growth factor‐1 (IGF‐1), which is know
Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr
## Abstract Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and recent phase II trials demonstrate activity in patients with endometrial cancer. Our objective was to examine the effects of combination therapy with rapamycin and paclita